Vol 6, No 2 (2015)

Hellenic Journal Of Atherosclerosis

DOI: http://dx.doi.org/10.23803/hja.v6i2

Table of Contents

Articles

Intensive glucose control in patients with type 2 diabetes mellitus and incidence of cardiovascular events. Has this issue been resolved?
K. Kaitanidis, C. Boutari, A. Lazaridis, M. Doumas, K. Tziomalos, V.G. Athyros
PDF
Metabolic syndrome, Barrett’s oesophagus, the risk of oesophageal adenocarcinoma, and statin treatment
Chrysoula Boutari, Stella-Maria Angelopoulou, Georgios Sfikas, Konstantinos Kaitanidis, Konstantinos Tziomalos, Vasilios G. Athyros
PDF
Non-alcoholic fatty liver disease in HIV-infected patients without viral hepatitis. What can we do about their cardiovascular risk?
Georgios Sfikas, Chrysoula Boutari, Konstandinos Tassios, Konstantinos Kaitanidis, Eydoxia Mitsiou, Vasilios G. Athyros
PDF
The use of dapagliflozin in the treatment of type 2 diabetes mellitus
Α. Liontos, E. Klouras, M. Florentin, E. Liberopoulos, M. Elisaf
PDF
SGLT2 inhibitors: what to expect in the future
Α. Liontos, E. Klouras, M. Florentin, E. Liberopoulos, M. Elisaf
PDF
The composite role of PCSK9 protein
E. Klouras, M. Elisaf
PDF
The role of PCSK9 protein in lipoprotein (a) metabolism
E. Klouras, M. Elisaf
PDF
CLOPIDOGREL BINDS TO Lp-PLA2 AND INHIBITS THE ENZYME ACTIVITY. A NEW PLEIOTROPIC EFFECT OF THIS ANTIPLATELET DRUG?
M.E. Tsoumani, C.C. Tellis, M.V. Chatziathanasiadou, A.N. Katsikoudi, V.G. Kontogianni, A.G. Tzakos, A.D. Tselepis
PDF
Comparative effectiveness of acenocoumarol and low-dose dabigatran in patients with atrial fibrillation and recent ischemic stroke in everyday clinical practice
Konstantinos Tziomalos, Vasilios Giampatzis, Stella D. Bouziana, Marianna Spanou, Stavroula Kostaki, Maria Papadopoulou, Stella-Maria Angelopoulou, Filitsa Konstantara, Christos Savopoulos, Apostolos I. Hatzitolios
PDF